Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance. - Wikidata - awgldk - TriplyDB

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.

http://www.wikidata.org/entity/Q35889609

about

Signatures of breast cancer metastasis at a glance ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis Identification of Aberrant Chromosomal Regions in Human Breast Cancer Using Gene Expression Data and Related Gene Information.Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.How interacting pathways are regulated by miRNAs in breast cancer subtypes.The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres.Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Astronomical algorithms for automated analysis of tissue protein expression in breast cancer.ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity.High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?The malignant social network: cell-cell adhesion and communication in cancer stem cells ALDH1A3 correlates with luminal phenotype in prostate cancer.Cancer stem cell marker glycosylation: Nature, function and significance.Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients.Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling.Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay.Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer

P2860

Q28071451-5ABB4A57-850F-47DF-8B64-C4EB97365525 Q28384120-92614B56-E4B7-435B-9D89-9FEFF8080C34 Q30990669-451A31FF-68EE-4BA3-A5A4-4E69B0DAE780 Q33659361-5EA5B5F5-F20A-484B-92D5-8FB5587A7EA4 Q33739278-12FCF962-847D-4139-8BF2-6B05574E7CD0 Q33892734-5A1B734D-46A3-4DEF-9F3D-963E79EB8A39 Q34158093-960BB14A-DBF7-4473-A904-7CEBA2179244 Q34654576-65000347-FD9F-4369-B031-38E4B8B2A1EF Q34731134-E8E91321-23FB-43FA-9682-1F80D02AE825 Q34773671-E3EDF0E8-C070-46F9-9DF4-BED2312A0621 Q35453612-4EE137EE-CA35-41E1-80AE-F5E7CE04510E Q35754821-18B11BFD-9BE1-487E-81BB-8F9C27D239A6 Q35827788-B4AAF920-351C-4188-84C4-A6F5A3B6B317 Q36170933-5FDCE5CD-B5B4-4405-A96F-9698BF44B72F Q36276533-65F1E4C1-80A9-4E5D-8594-5203A12AB55D Q36347067-7B64C3CF-9711-4847-AA28-31DE2850E7AC Q36472268-2427348F-1289-4B4F-9CB0-C170732BF635 Q36618624-5C3F28AC-529E-4A6E-BEA7-BEED0D59A9BC Q36671817-F59BB815-C6D9-49C7-ABF8-654460949E92 Q36714784-280F247D-2ACD-44B2-A5BA-535192EB38B8 Q36967608-FCBFA8B5-0201-4798-9CC5-B67938B6BE48 Q37461639-9ECC1348-6956-4C97-A596-91333C712D55 Q37507256-F78230C1-9BBC-4CCC-80F0-CCD34D22F359 Q37513954-5BCBAC8E-4FAD-4754-9D3B-BC3226E072A8 Q37615286-0E694B5E-050C-4E91-A57C-99683AACE23A Q38026421-A5FD09C4-DDDF-4031-9983-C42540D54ED4 Q38690835-8EAED924-5781-4693-999C-012927F0C143 Q39380552-D8E2E65C-3742-43F7-9248-87C9FA0B775D Q39828170-18323599-7FD3-4557-A015-C563BC826AD0 Q42440707-DC1EDC14-D11B-4F46-8177-31B7D24B6CFF Q42472874-B4587E5C-4875-4162-A7A6-2B16539DD758 Q42513994-0E8E7A86-D57A-446B-A553-E4B6C04E71DD Q45716446-38F250DE-67EB-495F-BC84-2677ABF725B9 Q47146042-342754DD-B875-453D-9DB0-B9395A23C118 Q52878728-B54394A2-51A1-49A3-97F4-A6F02D42E8CC Q58555555-18C9C3E8-777A-408E-8990-E4DA10D0E4F6

P2860

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.

http://www.wikidata.org/entity/Q35889609

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cancer stem cell markers in br ...... l and prognostic significance.

@ast

Cancer stem cell markers in br ...... l and prognostic significance.

@en

type

label

Cancer stem cell markers in br ...... l and prognostic significance.

@ast

Cancer stem cell markers in br ...... l and prognostic significance.

@en

prefLabel

Cancer stem cell markers in br ...... l and prognostic significance.

@ast

Cancer stem cell markers in br ...... l and prognostic significance.

@en

P1433

Q35889609-1FEE2A94-FBF3-4CDE-945F-1EB041F274D6

P1476

Q35889609-343E2854-CF11-4407-9C6F-E20D40F90EBC

P2093

Q35889609-367F0E07-1697-4E53-942B-23DB1BE1589B

Q35889609-8EC8E2B1-8C36-41A5-8D35-6705CFEAF84D

Q35889609-EB0ECCBC-A0D8-4DB6-9E84-EEAA59D274E4

Q35889609-F859D7A7-240B-470D-9EF1-149E7C443563

P2860

Q35889609-0051AC84-934B-47ED-9C7D-7C645A30809D

Q35889609-13291DB3-83D4-4604-A9BF-E703A5B0C473

Q35889609-202D14BC-2501-41FE-AEB6-F91526CE65CB

Q35889609-202D866F-7F6B-43D4-B140-F259B025C894

Q35889609-2239B4B1-9B16-4054-AF8B-2D533A7279F6

Q35889609-2A08B509-FBA1-4093-8038-1CEA5D222D61

Q35889609-344AF5CE-CEF6-44ED-B8A2-8A70A6B0CEC2

Q35889609-4D97699F-1FC0-42FE-A7ED-33025E0B1E0F

Q35889609-503A6FCE-7BC1-4C90-8BC0-474EB31C7041

Q35889609-51A87E2C-9DAD-4D99-9EEF-F6851F567660

P2888

Q35889609-4D61F3C2-693C-4096-898A-C5356EB319B7

P304

Q35889609-56C52BB2-FD0A-4F86-B82D-D7AFC5952790

P31

Q35889609-86B7EBBD-35C1-4C00-9427-BFD36A3C7E13

P356

Q35889609-92133C79-13D0-4235-AD71-8A8D54B4EB71

P433

Q35889609-94855647-C2C6-4558-85B4-93141FBEFEE8

P478

Q35889609-C00665C2-B264-4136-8D3B-ED3BF8DACD38

P50

Q35889609-B05526B0-0AFD-4C7E-BD5C-7C359DD19C61

Q35889609-D2354899-3623-4C9D-8EF3-72EAA6C21126

P577

Q35889609-2C26A30F-2DA5-487A-8DB3-5A714867AA0C

P5875

Q35889609-C74EBDB8-3D69-4721-AB57-E8A59DED8E30

P6179

Q35889609-2574A49D-43F6-4C3F-8274-0783028B54F2

P698

Q35889609-CF01CF28-E039-4763-8ADC-D7295B1B37C6

P932

Q35889609-4CAAC60A-6820-4203-881D-D5DBC1FF6003

P356

P1433

Breast Cancer Research

P1476

Cancer stem cell markers in br ...... l and prognostic significance.

@en

P2093

Elena Provenzano

http://www.w3.org/2001/XMLSchema#string

Fiona M Blows

http://www.w3.org/2001/XMLSchema#string

H Raza Ali

http://www.w3.org/2001/XMLSchema#string

Sarah-Jane Dawson

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Cluster analysis and display of genome-wide expression patterns

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Stem cells, cancer, and cancer stem cells

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

Molecular definition of breast tumor heterogeneity

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers

Purification and unique properties of mammary epithelial stem cells

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

P2888

P304

R118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3061

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Paul D P Pharoah

P577

2011-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51827498

http://www.w3.org/2001/XMLSchema#string

P6179

1036388460

http://www.w3.org/2001/XMLSchema#string

P698

22112299

http://www.w3.org/2001/XMLSchema#string

P932

3326560

http://www.w3.org/2001/XMLSchema#string